LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | R406 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2759 | 3124 | 0.8832 | 0.8454 |
Hs 578T | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 765 | 2186 | 3124 | 0.6998 | 0.6025 |
Hs 578T | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 765 | 3041 | 3124 | 0.9735 | 0.9649 |
Hs 578T | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 765 | 838 | 3124 | 0.2682 | 0.0309 |
Hs 578T | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 765 | 963 | 3124 | 0.3082 | 0.0839 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 765 | 2759 | 3124 | 0.8831 | 0.8452 |
Hs 578T | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2413 | 3124 | 0.7724 | 0.6986 |
Hs 578T | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 765 | 2929 | 3124 | 0.9376 | 0.9174 |
Hs 578T | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 765 | 720 | 3124 | 0.2305 | -0.0190 |
Hs 578T | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 765 | 2482 | 3124 | 0.7946 | 0.7280 |
Hs 578T | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 765 | 2379 | 3124 | 0.7614 | 0.6840 |
Hs 578T | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 765 | 2863 | 3124 | 0.9165 | 0.8894 |
Hs 578T | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 765 | 3009 | 3124 | 0.9631 | 0.9512 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 765 | 3128 | 3124 | 1.0011 | 1.0015 |
Hs 578T | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 765 | 3104 | 3124 | 0.9935 | 0.9914 |
Hs 578T | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2846 | 3124 | 0.9110 | 0.8821 |
Hs 578T | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 765 | 3026 | 3124 | 0.9685 | 0.9582 |
Hs 578T | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 765 | 2856 | 3124 | 0.9143 | 0.8865 |
Hs 578T | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 765 | 3054 | 3124 | 0.9774 | 0.9701 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3166 | 3124 | 1.0135 | 1.0179 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 765 | 698 | 3124 | 0.2236 | -0.0281 |
Hs 578T | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 765 | 669 | 3124 | 0.2141 | -0.0407 |
Hs 578T | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 765 | 2440 | 3124 | 0.7811 | 0.7102 |
Hs 578T | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 2591 | 3124 | 0.8294 | 0.7740 |
Hs 578T | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3572 | 3124 | 1.1432 | 1.1896 |